IRIS
COLOMBO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.181
EU - Europa 420
AS - Asia 407
AF - Africa 12
SA - Sud America 5
OC - Oceania 2
Totale 2.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.181
CN - Cina 193
SG - Singapore 183
IE - Irlanda 180
FI - Finlandia 153
DE - Germania 29
IT - Italia 27
IN - India 18
SE - Svezia 13
NG - Nigeria 9
BR - Brasile 4
RU - Federazione Russa 4
TW - Taiwan 4
FR - Francia 3
HK - Hong Kong 3
UA - Ucraina 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
JP - Giappone 2
NL - Olanda 2
UG - Uganda 2
CL - Cile 1
CY - Cipro 1
ES - Italia 1
GB - Regno Unito 1
IL - Israele 1
KE - Kenya 1
PH - Filippine 1
UZ - Uzbekistan 1
Totale 2.027
Salva come PNG Salva come JPEG
Città #
Ashburn 319
Boardman 205
Shanghai 187
Dublin 180
New York 175
Helsinki 153
Singapore 131
Los Angeles 40
Chandler 38
Seattle 36
Wilmington 23
Pune 15
Phoenix 14
Santa Clara 12
Benin City 9
San Mateo 9
Ann Arbor 5
Turin 5
Brasília 4
Lawrence 4
Leawood 4
Moscow 4
Princeton 4
Taipei 4
Torre del Lago Puccini 4
Clifton 3
Hangzhou 3
Monza 3
Mykolayiv 3
Paris 3
Amsterdam 2
Brno 2
Brussels 2
Carbonara al Ticino 2
Hong Kong 2
Kampala 2
Milan 2
Redondo Beach 2
Rome 2
Woodbridge 2
Brescia 1
Bristol 1
Brookville 1
Fairfield 1
Horn Lake 1
Madrid 1
Makati City 1
Munich 1
Nairobi 1
Newcastle 1
Nicosia 1
Norwalk 1
Perth 1
Pulandian 1
Rozzano 1
San Francisco 1
San Severo 1
Toyonaka 1
Trentola-Ducenta 1
Totale 1.638
Salva come PNG Salva come JPEG
Nome #
A Propensity Score Matched Comparative Study Between Paclitaxel-Coated Balloon and Everolimus-Eluting Stents for the Treatment of Small Coronary Vessels 55
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 50
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 43
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 28
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 25
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 25
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 25
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 22
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 22
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 20
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 20
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 20
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 19
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 19
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 19
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 18
[40 Years of coronary angioplasty: success comes from skills and determination!] 18
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 18
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 18
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 17
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 17
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 16
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 16
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 16
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals 16
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 16
Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients 15
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 15
Advances in percutaneous interventional therapies: The tricuspid valve 15
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 15
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 15
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 15
Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience 14
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 14
[New therapeutic options for the treatment of tricuspid regurgitation] 14
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 14
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 14
Five Year Outcomes Following Drug-eluting Stents Implantation vs. Coronary Artery Bypass Graft Surgery for Unprotected Left Main Coronary Artery Lesions: Milan Experience 14
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 13
Intraarterial thrombolysis for treatment of peripheral graft thrombosis: advantage of the radial approach 13
Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture" 13
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 13
White blood cell count and major adverse cardiovascular events after percutaneous coronary intervention in the contemporary era insights from the Paris study (Patterns of non-adherence to anti-platelet regimens in stented patients registry) 13
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 13
Prognostic value of tricuspid regurgitation 13
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 13
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 13
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 13
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 13
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 13
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 13
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 13
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 12
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 12
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 12
Use of Echocardiography for Guiding Percutaneous Tricuspid Valve Procedures 12
Diabetes and mortality in patients with COVID-19: Are we missing the link? 12
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 12
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 12
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: Early results of the feasibility trial 11
How should i treat recurrent restenosis with underexpanded multilayered struts after repeated complex bifurcation stenting? 11
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 11
ONE-YEAR CLINICAL OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) WITH BOTH EDWARDS SAPIEN AND COREVALVE DEVICES IN A SINGLE CENTER: THE MILAN EXPERIENCE 11
Need for permanent pacemaker implantation after corevalve, sapien and surgical aortic valve replacement: incidence, time course and predictive factors 11
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 11
First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease 11
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 11
Clinical and anatomical predictors of mitraclip therapy failure for functional mitral regurgitation 11
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 11
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 11
One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients 11
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 10
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 10
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 10
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 10
Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions 10
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 10
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 10
The coronary sinus reducer: clinical evidence and technical aspects 10
Percutaneous treatment of periprosthetic mitral valve leaks: Is it just a futile exercise? 10
Subintimal Crush of an Occluded Stent to Recanalize a Chronic Total Occlusion Due to In-Stent Restenosis: Insights From a Multimodality Imaging Approach 10
Repeat MitraClip for early recurrent mitral regurgitation 10
Procedural and longer-term outcomes of wire- versus device-based antegrade dissection and re-entry techniques for the percutaneous revascularization of coronary chronic total occlusions 10
Transfemoral Lotus Valve Implantation for Treatment of Postendocarditis Stentless Prosthesis Degeneration With Pure Aortic Regurgitation 10
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 10
Percutaneous Tricuspid Valve Annuloplasty Under Conscious Sedation (With Only Fluoroscopic and Intracardiac Echocardiography Monitoring) 10
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions 10
Stent loss during chronic total occlusion percutaneous coronary intervention: Optical coherence tomography-guided stent 'crushing and trapping' 10
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study 10
Prognostic implications of the relationship between effective regurgitant orifice area and left ventricle end diastolic volume in patients with functional mitral regurgitation treated with MitraClip 10
The Evolution From Surgery to Percutaneous Mitral Valve Interventions The Role of the Edge-to-Edge Technique 10
Resource utilization for transfemoral transcatheter aortic valve replacement: An international comparison 10
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis 10
Successful implantation of a second-generation aortic valve in severe aortic regurgitation secondary to a traumatic cusp lesion 10
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 10
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial? 9
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study 9
Impact of crossing strategy on mid-term outcomes following percutaneous revascularisation of coronary chronic total occlusions 9
New frontiers in interventional cardiology: Percutaneous treatment of tricuspid regurgitation 9
Ventricular septal defect and left ventricular outflow tract obstruction after transcatheter aortic valve implantation 9
Totale 1.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202137 0 1 0 0 0 14 8 2 9 0 0 3
2021/202222 1 0 0 6 0 0 1 5 0 1 7 1
2022/2023399 9 4 8 24 21 11 2 10 47 37 208 18
2023/20241.685 107 79 387 139 131 315 79 73 26 54 134 161
2024/202576 71 5 0 0 0 0 0 0 0 0 0 0
Totale 2.220